Moulin, M; Anderton, H; Voss, A K; Thomas, T; Wong, W W L; Bankovacki, A; Feltham, R; Chau, D; Cook, W D; Silke, J; Vaux, D L (2012). IAPs must limit activation of RIP kinases by TNF Receptor 1 to prevent embryonic lethality. EMBO Journal Online, 31(7):1679-1691.
Kraft, M; Cirstea, I C; Voss, A K; Thomas, T; Goehring, I; Sheikh, B N; Gordon, L; Scott, H; Smyth, G K; Ahmadian, M R; Trautmann, U; Zenker, M; Tartaglia, M; Ekici, A; Reis, A; Dörr, H G; Rauch, A; Thiel, C T (2011). Disruption of the histone acetyltransferase MYST4 leads to a Noonan syndrome-like phenotype and hyperactivated MAPK signaling in humans and mice. Journal of Clinical Investigation, 121(9):3479-3491.
Yazdanpanah, Y; De Carli, G; Migueres, B; Lot, F; Campins, M; Colombo, C; Thomas, T; Deuffic-Burban, S; Prevot, M H; Domart, M; Tarantola, A; Abiteboul, D; Deny, P; Pol, S; Desenclos, J C; Puro, V; Bouvet, E (2005). Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control study. Clinical Infectious Diseases, 41(10):1423-1430.
Katschinski, D M; Le, L; Schindler, S G; Thomas, T; Voss, A K; Wenger, R H (2004). Interaction of the PAS B domain with HSP90 accelerates hypoxia-inducible factor-1alpha stabilization. Cellular Physiology and Biochemistry, 14(4-6):351-360.